85 related articles for article (PubMed ID: 18322167)
21. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.
Cho H; Kang H; Lee HH; Kim CW
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703774
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers.
Liu Y; Cheng Y; Xu Y; Wang Z; Du X; Li C; Peng J; Gao L; Liang X; Ma C
Oncogene; 2017 Nov; 36(44):6143-6153. PubMed ID: 28692048
[TBL] [Abstract][Full Text] [Related]
23. CD56
Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
[TBL] [Abstract][Full Text] [Related]
24. Interferon-α-induced CD100 on naïve CD8
Li BJ; He Y; Zhang Y; Guo YH; Zhou Y; Zhang PX; Wang W; Zhao JR; Li JG; Zuo WZ; Fan C; Jia ZS
J Int Med Res; 2017 Feb; 45(1):89-100. PubMed ID: 28222623
[TBL] [Abstract][Full Text] [Related]
25. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.
Beldi-Ferchiou A; Lambert M; Dogniaux S; Vély F; Vivier E; Olive D; Dupuy S; Levasseur F; Zucman D; Lebbé C; Sène D; Hivroz C; Caillat-Zucman S
Oncotarget; 2016 Nov; 7(45):72961-72977. PubMed ID: 27662664
[TBL] [Abstract][Full Text] [Related]
26. Metabolic regulation of immune responses: therapeutic opportunities.
Assmann N; Finlay DK
J Clin Invest; 2016 Jun; 126(6):2031-9. PubMed ID: 27249676
[TBL] [Abstract][Full Text] [Related]
27. CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.
Sheiko MA; Golden-Mason L; Giugliano S; Hurtado CW; Mack CL; Narkewicz MR; Rosen HR
J Pediatr; 2016 Mar; 170():142-8.e1. PubMed ID: 26743497
[TBL] [Abstract][Full Text] [Related]
28. High post-treatment absolute monocyte count predicted hepatocellular carcinoma risk in HCV patients who failed peginterferon/ribavirin therapy.
Chen TM; Lin CC; Huang PT; Wen CF
Tumour Biol; 2016 Jun; 37(6):7129-37. PubMed ID: 26662957
[TBL] [Abstract][Full Text] [Related]
29. Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.
Le Chenadec J; Scott-Algara D; Blanche S; Didier C; Montange T; Viard JP; Dollfus C; Avettand-Fenoel V; Rouzioux C; Warszawski J; Buseyne F
PLoS One; 2015; 10(12):e0144706. PubMed ID: 26650393
[TBL] [Abstract][Full Text] [Related]
30. A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients.
Xu Y; Huang P; Yue M; Su J; Chen H; Chen M; Wang J; Li J; Peng Z; Zhang Y; Yu R
J Hum Genet; 2016 Apr; 61(4):301-5. PubMed ID: 26632884
[TBL] [Abstract][Full Text] [Related]
31. Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy.
Salem ML; El-Badawy A
World J Hepatol; 2015 Oct; 7(23):2449-58. PubMed ID: 26483866
[TBL] [Abstract][Full Text] [Related]
32. Immune and non-immune responses to hepatitis C virus infection.
Sun J; Rajsbaum R; Yi M
World J Gastroenterol; 2015 Oct; 21(38):10739-48. PubMed ID: 26478666
[TBL] [Abstract][Full Text] [Related]
33. Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules.
Solaymani-Mohammadi S; Lakhdari O; Minev I; Shenouda S; Frey BF; Billeskov R; Singer SM; Berzofsky JA; Eckmann L; Kagnoff MF
J Leukoc Biol; 2016 Mar; 99(3):475-82. PubMed ID: 26467188
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.
Larrubia JR; Moreno-Cubero E; Miquel J; Sanz-de-Villalobos E
World J Gastroenterol; 2015 Mar; 21(12):3480-91. PubMed ID: 25834312
[TBL] [Abstract][Full Text] [Related]
35. Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.
Rehermann B; Bertoletti A
Hepatology; 2015 Feb; 61(2):712-21. PubMed ID: 25048716
[TBL] [Abstract][Full Text] [Related]
36. Regulatory phenotype, PD-1 and TLR3 expression in T cells and monocytes from HCV patients undergoing antiviral therapy: a randomized clinical trial.
Su SS; He H; Kong LB; Zhang YG; Zhao SX; Wang RQ; Zheng HW; Sun DX; Nan YM; Yu J
PLoS One; 2014; 9(4):e93620. PubMed ID: 24709775
[TBL] [Abstract][Full Text] [Related]
37. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
[TBL] [Abstract][Full Text] [Related]
38. Emerging concepts in immunity to hepatitis C virus infection.
Rosen HR
J Clin Invest; 2013 Oct; 123(10):4121-30. PubMed ID: 24084744
[TBL] [Abstract][Full Text] [Related]
39. PD-1 coinhibitory signals: the link between pathogenesis and protection.
Kulpa DA; Lawani M; Cooper A; Peretz Y; Ahlers J; Sékaly RP
Semin Immunol; 2013 Oct; 25(3):219-27. PubMed ID: 23548749
[TBL] [Abstract][Full Text] [Related]
40. Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.
Söderholm J; Waldenström J; Askarieh G; Pilli M; Bochud PY; Negro F; Pawlotsky JM; Zeuzem S; Ferrari C; Norkrans G; Wejstål R; Westin J; Neumann AU; Haagmans BL; Lindh M; Missale G; Hellstrand K; Lagging M
PLoS One; 2013; 8(2):e56991. PubMed ID: 23437290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
